Type 2 Inflammatory Skin Diseases / Atopic Dermatitis

Agenda / Program Outline

The 16th RAJKA Symposium Beijing 2026 — Industry Workshop at ISAD Beijing 2026

Date:​ October 18, 2026

Time:​ 13:45 – 15:15 CST / Local Time (Beijing)

Venue:​ Ballroom C

Duration:​ 90 minutes

Product / Compound:​ Dupilumab

Chairperson / Moderator:​ Prof. Linfeng LI

Focus

Educational Objectives

By the end of this 90-minute industry workshop, participants will discuss:

  • Updated clinical evidence and emerging approaches in pediatric atopic dermatitis care;
  • Mechanisms of itch/prurigo across type 2 inflammatory skin diseases;
  • The potential role of dual-channel / IL-4/IL-13 pathway inhibition in type 2 inflammatory skin diseases;
  • Clinical implications and real-world considerations through expert panel discussion.

Detailed Agenda

13:45
13:55
10 min.
SAN1
Opening, Welcome Remarks, Disclosures and Symposium Objectives

Prof. Linfeng LI, Chairman / Moderator

13:55
14:25
30 min.
SAN2
Pediatric AD Care Reimagined: Updated Clinical Evidence and the Next Frontier

Prof. Lawrence EICHENFIELD, Presenter

14:25
14:55
30 min.
SAN3
Prurigo and Itch Mechanisms Across Type 2 Inflammatory Skin Diseases: Dual-Channel Inhibition and Clinical Implications

Prof. Sonja STÄNDER, Presenter

14:55
15:15
20 min.
SAN4
Panel Discussion

All Faculty Moderated by Prof. Linfeng LI

 
20260923153048